Literature DB >> 31396774

Synthesis and biological evaluation of 1,2,4-triazolidine-3-thiones as potent acetylcholinesterase inhibitors: in vitro and in silico analysis through kinetics, chemoinformatics and computational approaches.

Prasad G Mahajan1, Nilam C Dige2, Balasaheb D Vanjare1, Hussain Raza2, Mubashir Hassan3, Sung-Yum Seo4, Chong- Hyeak Kim5, Ki Hwan Lee6.   

Abstract

We have designed and synthesized a novel acidic ionic liquid and explored its catalytic efficiency for the synthesis of 1,2,4-triazolidine-3-thione derivatives. A simple reaction between aldehydes and thiosemicarbazide for short time in 60:40 v/v water/ethanol at room temperature offers target 1,2,4-triazolidine-3-thione derivatives. The formation of target compounds is confirmed by NMR, IR and ESI-MS analysis. Pleasingly, synthesized compounds show noteworthy acetylcholinesterase (AChE) inhibitory activity with much lower IC50 values 0.0269 ± 0.0021-1.1725 ± 0.0112 μM than standard Neostigmine methylsulphate. In addition, synthesized 1,2,4-triazolidine-3-thiones exhibits significant free radical scavenging activity as compared to standard vitamin C. The studies on validation of Lipinski's rule through chemoinformatics properties and molecular docking analysis are in support of in vitro analysis. Therefore, overall present study illustrates synthesis of some new 1,2,4-triazolidines-3-thiones which can serve as a template for drug designing such as AChE inhibitors. Herein, we proposed ionic liquid-catalyzed ease of synthetic approach for medicinally important 1,2,4-triazolidine-3-thiones and their bio-evaluations.

Entities:  

Keywords:  1,2,4-triazolidine-3-thiones; Acetylcholinesterase inhibition; Ionic liquid; Lipinski rule; Molecular docking

Mesh:

Substances:

Year:  2019        PMID: 31396774     DOI: 10.1007/s11030-019-09983-y

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  1 in total

1.  Regioselective and stereoselective synthesis of epithiomethanoiminoindeno[1,2-b]furan-3-carbonitrile: heterocyclic [3.3.3]propellanes.

Authors:  Alaa A Hassan; Nasr K Mohamed; Ashraf A Aly; Hendawy N Tawfeek; Stefan Bräse; Martin Nieger
Journal:  Mol Divers       Date:  2020-01-09       Impact factor: 2.943

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.